Genentech’s CEO, Ian T. Clark, Named as the Healthcare Businesswomen’s Association’s 2011 Honorable Mentor

February 11, 2011

FAIRFIELD, N.J., Feb. 11, 2011 /PRNewswire-USNewswire/ — The Healthcare Businesswomen’s Association (HBA) today announced that it has named Ian T. Clark, Genentech’s chief executive officer and head of North American commercial operations, as its 2011 Honorable Mentor. He will be formally recognized at the 22nd annual “Woman of the Year” (WOTY) Luncheon on Thursday, May 5, 2011 – the premier event of the year for the healthcare community, attended by over 2,000 industry leaders.

(Logo: http://photos.prnewswire.com/prnh/20110211/DC46975 )

“I am proud of Genentech’s longtime partnership with the Healthcare Businesswomen’s Association,” said Mr. Clark. “I am delighted to be named this year’s Honorable Mentor, and am committed to investing in the advancement of women in our healthcare industry.”

The HBA created the Honorable Mentor award eleven years ago to recognize one individual each year who demonstrates long-term support of the advancement of women in the healthcare industry, has a personal dedication to developing, mentoring and promoting women in the industry, and who has been supportive of the HBA.

“The Healthcare Businesswomen’s Association is pleased to recognize Ian Clark as our 2011 HBA Honorable Mentor, for his dedication to enhancing and accelerating the stature and accomplishments of women in healthcare,” said Deborah Coogan Seltzer, HBA president and life sciences practice member, Spencer Stuart. “Women at all companies would be very fortunate to have a champion like Ian Clark.”

Mr. Clark serves as chief executive officer and head of North American commercial operations at Genentech Inc, a member of the Roche Group, and sits on Genentech’s board of directors. Previously, he was chief marketing officer and head of global product strategy for Roche Pharma and Genentech. In an earlier role, Mr. Clark served as executive vice president of commercial operations at Genentech.

Before joining Genentech in 2003, he served as president of Novartis Canada, overseeing all of its country operations and, prior to this, as chief operating officer for Novartis in the United Kingdom. Mr. Clark worked in vice presidential roles in sales and marketing for sanofi-aventis and Ivax in the United Kingdom and Eastern Europe. He is on the board of directors of the Biotechnology Industry Organization (BIO). Mr. Clark earned a bachelor of science degree in Biological Sciences from Southampton University.

“Ian Clark is a dedicated champion of the advancement of women at Genentech,” said Carol Wells, Genentech’s senior director for commercial leadership and development and president of HBA’s San Francisco Chapter. “Through his leadership, Genentech has initiated an annual Women’s Leadership Summit on current issues for women in business today. With his passion for diversity and action-driven mentoring approach, he is a powerful voice in support of women leaders in general.”

About The HBA

The Healthcare Businesswomen’s Association (HBA; www.hbanet.org) is in its fourth decade as a global not-for-profit organization dedicated to furthering the advancement of women in healthcare worldwide. With 15 chapters and affiliates throughout the U.S. and in Europe, the HBA is headquartered in New Jersey with offices in Philadelphia and Research Triangle Park. The HBA provides educational opportunities for women and men to develop cutting-edge healthcare industry knowledge and leadership skills; recognizes outstanding women and men in the industry; provides opportunities for networking; creates greater visibility for women in the industry; fosters mentoring relationships and serves as a conduit and sponsor for research on career advancement issues. HBA has nearly 6,000 individual members and over 120 Corporate Partners. It is widely recognized as the catalyst for leadership development of women in healthcare worldwide. For more information, visit www.hbanet.org.

SOURCE Healthcare Businesswomen’s Association

Source: newswire

comments powered by Disqus